About
Treatments for weight management and metabolic disease
Areas of Focus
Categories
Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
9
As Collaborator
0
Total Enrollment
533
By Phase
PHASE2: 8PHASE1: 1
By Status
COMPLETED: 8ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06640972Lead Sponsor
Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists
PHASE2Active, not recruiting
68 participants
Started: Sep 27, 2024 · Completed: Apr 30, 2025
NCT05857566Lead Sponsor
Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine
PHASE1Completed
24 participants
Started: May 16, 2023 · Completed: Sep 13, 2023
NCT02434744Lead Sponsor
Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus
PHASE2Completed
121 participants
Started: Apr 30, 2015 · Completed: Mar 31, 2016
NCT00871936Lead Sponsor
A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes
PHASE2Completed
82 participants
Started: Apr 30, 2009 · Completed: Oct 31, 2009
NCT00810979Lead Sponsor
Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia
PHASE2Completed
133 participants
Started: Jan 31, 2009 · Completed: Sep 30, 2009
Locations (1)
Headquarters
Falls Church, VA, United States
Map
Loading map...